The company, founded in 2001, has accelerated its international expansion plan. With this purchase, 50% of its business volume will be generated outside of Spain.
Pharmaprogress, located in the city of Ancona, specialises in contract research and analysis services and expects to post turnover of €1 million in 2017.
